<\/strong><\/span><\/h4>\n<\/strong><\/span><\/p>\n<\/strong><\/span><\/p>\n<\/strong><\/span><\/p>\nProf. Dr.\u00a0Deleanu Diana<\/strong><\/span>
Universitatea de Medicin\u0103 \u0219i Farmacie”Iuliu Ha\u021bieganu”, Cluj Napoca<\/strong><\/span><\/h4>\n[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=”3.25″ locked=”off”][et_pb_column type=”4_4″ _builder_version=”3.25″ custom_padding=”|||” custom_padding__hover=”|||”][et_pb_text _builder_version=”4.9.7″ hover_enabled=”0″ sticky_enabled=”0″]<\/p>\n
Inhibitorii JAK kinazelor in dermatita atopica
Autori: Diana Deleanu, Irena Pintea
<\/span><\/p>\nUniversitatea de Medicina si Farmacie \u201cIuliu Hatieganu\u201d, Institutul Regional de Gastroenterologie si Hepatologie \u201cProf dr. Octavian Fodor\u201d \u2013 Alergologie; Cluj-Napoca<\/p>\n
Cuvinte cheie: dermatita atopica, JAK inhibitori, imunomodulare<\/p>\n
Dermatita atopica (DA) este cea mai frecventa afectiune inflamatorie cronica a pielii in perioada copilarie, si doar la unii dintre copii se amelioreaza in timp. Mecanismul de producere a DA implica si activarea sistemului imun cu rol important jpentru limfocitele Th2, dar si alte subtipuri de limfocite intervin (Th22, Th1, Th17). Enzimele legate de receptorii membranari pentru citokine, numite JAK kinase reprezinta semnalul al doilea de activare a indusa de citokine, precum IL-4, IL-13, IL-22, IL-23, IL-31, IL-33, IFN-\u03b3. JAK kinazele fosforileaza sistemul STAT (semnalul de activare si traducere a transcriptiei), iar factorii nucleari activati declanseaza sinteza altor citokine. Au fost sintetizate substante ce blocheaza activarea JAK kinazelor. Aceste noi molecule (inhibitorii JAK) au ca efect blocarea activarii limfocitelor si prin aceasta reduc efectele intilnite in boli inflamatorii, printre care se numara si DA. JAK inhibitorii au ca tinta diferite enzime JAK (JAK1, JAK2, JAK3), dar au efecte clinice comune. JAK inhibitorii (baricitinib, tofacitinib etc) se pot administra topic sau oral, iar in studiile clinic (inclusive de faza III) au scazut severitatea simptomelor si semnelor din DA (prurit, eritem etc), siguranta lor fiind mare. Studiile cu aceste medicamente noi, a caror tinta sunt moleculele mici sunt terminate sau in plina desfasurare, astfel incit aprobarea pentru tratamentul DA este aproape. In concluzie. O noua clasa de medicamente, JAK inhibitorii, cu efecte imunomodulatoare si antiinflamatorii, care actioneaza prin blocharea enzimele intracitoplasmatice este la orizont pentru tratamentul DA moderate si severe. JAK inhibitorii sunt eficienti, usor de administrat si au un profil de siguranta mare.<\/p>\n
JAK Inhibitors for the treatment of atopic dermatitis
Autori: Diana Deleanu, Irena Pintea
<\/span><\/p>\nUniversity of Medicine & Pharmacy \u201cIuliu Hatieganu\u201d, Regional Institute of Gastroenterology and \u00a0Hepatology \u201cProf dr. Octavian Fodor\u201d \u2013 Allergology; Cluj-Napoca<\/p>\n
Key words: atopic dermatitis, JAK inhibitors, immunomodulation<\/p>\n
Atopic dermatitis (AD) is one of the most frequent inflammatory skin diseases in childhood, and few of the children out-grow their disease. AD is driven by abnormal immune activation of T helper (Th) 2, but also other subtypes of T cells are involved (Th22, Th1 and Th17). The Janus kinase (JAK)-signal transducer and activator of transcription (STAT) are involved in signaling of several AD-related cytokines, such as IFN-\u03b3, IL-4, IL-13, IL-31, IL-33, IL-23, IL-22, and IL-17, mediating downstream inflammation and barrier alterations. A new class of drugs is developed, and their action is inhibitory on JAK-kinase. The JAK inhibitors, which target different combinations of kinases (JAK1, JAK2, JAK3), have overlapping but distinct mechanisms of action, all of them being efficient and safe. Several topical and oral JAK inhibitors have been shown to decrease AD severity and symptoms. The available data from clinical studies are promising regarding therapeutics and safety effects, so in the next future the approval of JAK inhibitors in AD is expected. In conclusion: a new class of medication, JAK inhibitors, with immunomodulatory and anti-inflammatory effects, acting as inhibitors of intracytoplasmatic enzymes, are on pipe line to be approved in the therapy of AD (moderate and severe). JAK inhibitors are efficient, easy to administrate and the have a safety profile.<\/p>\n
Scurt CV<\/span><\/p>\nA absolvit Facultatea de Medicina si Farmacie a Institutului de Medicina si Farmacie Cluj-Napoca (actuala Universitate de Medicina si Farmacie Iuliu Hatieganu) in 1983. Este medic primar de Medicina Interna si de Alergologie si Imunologie Clinica (din 1995). Este angajata la UMF Iuliu Hatieganu, disciplina de Imunologie si Alergologie (sef de disciplina) si la Institutul Regional de Gastroenterologie si Hepatologie (IRGH) \u201cProf. dr. Octavian Fodor\u201d, sectia Medicina Interna (sef de sectie) cu compartimente de Alergologie si de Imunologie. Conduce programul nationale pentru boli rare \u2013 imunodeficiente primare.
Specializari la UMF Cluj-Napoca, UMF Carol Davila, Bucuresti, Universitatea de Medicina Southampton (boli respiratorii), la Spitalul Brompton, Londra, Serviciul de recuperare boli respiratorii Paderborn, la Clinica Nantes, Universitatea Navarra, Clinica San Miguel (alergologie) din Pamplona. Si-a sustinut teza de doctorat in domeniul medicine cu o tema de imunologie, in 1996. Autoare si coautoare a numeroase articole, cu indice Hirsch peste 9 si autoare la mai multe carti, capitole de carte in domeniul imunologiei si alergologiei. A introdus teste de provocare si imunoterapia specifica. Preda cursuri de imunologie si alergologie la studentii de la UMF “Iuliu Hatieganu” Cluj-Napoca, la anul 3 si 6 medicina generala, la medicina dentara, farmacie, nutritie si este responsabila de pregatirea medicilor rezidenti in specialitatea de Alergologie si Imunologie Clinica. Este investigator principal in numeroase studii clinice internationale privind bolile alergice (astm, rinita, soc anafilactic, urticarie). Participant la numeroase manifestarii de medicina, imunologie, alergologie, pediatrie, dermatologie regionale, nationale si internationale. A organizat “Scoala de Vara” 2007 la Cluj-Napoca, impreuna cu Academia Europeana de Alergologie si Imunologie Clinica (EAACI). A fost vicepresedinte (200-2006) si presedinte (2006-20017) al Societatii Nationale de Alergologie si Imunologie Clinica (SRAIC) , in prezent este \u201cfost-presedinte\u201d al SRAIC. Este membra la mai multe societati internationale de alergologie (EAACI, organizatia mondiala de Alergologie \u2013 WAO, la AAAAI, la ACAAI etc) si face parte din Comisiile de specialitate ale MS si Colegiului Medicilor. Are doi copii si trei nepoti.<\/p>\n
[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”3.22″ background_color=”rgba(117,194,33,0.23)” background_image=”https:\/\/pdi.ro\/2021\/wp-content\/uploads\/2020\/02\/back_justflowers_overlay1.png” background_blend=”luminosity” custom_padding=”54px|0px|0|0px|false|false” top_divider_style=”waves2″ top_divider_color=”#ffffff” top_divider_height=”155px” top_divider_height_tablet=”” top_divider_height_phone=”97px” top_divider_height_last_edited=”on|desktop” bottom_divider_style=”waves2″ bottom_divider_color=”#75c221″ bottom_divider_flip=”vertical” bottom_divider_height_tablet=”” bottom_divider_height_phone=”59px” bottom_divider_height_last_edited=”on|desktop”][et_pb_row column_structure=”3_5,2_5″ _builder_version=”3.25″ custom_padding=”61px|0px|69px|0px|false|false”][et_pb_column type=”3_5″ _builder_version=”3.25″ custom_padding=”|||” custom_padding__hover=”|||”][et_pb_text _builder_version=”4.0.11″ text_font=”Kaushan Script||||||||” text_text_color=”#f0622a” text_font_size=”30px” text_line_height=”1.2em” header_font=”||||||||” background_layout=”dark” text_font_size_tablet=”” text_font_size_phone=”” text_font_size_last_edited=”on|desktop”]<\/p>\n
Contacteaz\u0103 operatorul PDI 2020<\/p>\n
[\/et_pb_text][et_pb_contact_form email=”contact@pdi.ro\/2021\/2019″ submit_button_text=”Trimite mesajul” _builder_version=”3.19.4″ title_font=”||||||||”][et_pb_contact_field field_id=”Name” field_title=”Nume” _builder_version=”3.18.9″ button_text_size__hover_enabled=”off” button_one_text_size__hover_enabled=”off” button_two_text_size__hover_enabled=”off” button_text_color__hover_enabled=”off” button_one_text_color__hover_enabled=”off” button_two_text_color__hover_enabled=”off” button_border_width__hover_enabled=”off” button_one_border_width__hover_enabled=”off” button_two_border_width__hover_enabled=”off” button_border_color__hover_enabled=”off” button_one_border_color__hover_enabled=”off” button_two_border_color__hover_enabled=”off” button_border_radius__hover_enabled=”off” button_one_border_radius__hover_enabled=”off” button_two_border_radius__hover_enabled=”off” button_letter_spacing__hover_enabled=”off” button_one_letter_spacing__hover_enabled=”off” button_two_letter_spacing__hover_enabled=”off” button_bg_color__hover_enabled=”off” button_one_bg_color__hover_enabled=”off” button_two_bg_color__hover_enabled=”off”][\/et_pb_contact_field][et_pb_contact_field field_id=”Email” field_title=”Adresa de e-mail” field_type=”email” _builder_version=”3.19.4″ button_text_size__hover_enabled=”off” button_one_text_size__hover_enabled=”off” button_two_text_size__hover_enabled=”off” button_text_color__hover_enabled=”off” button_one_text_color__hover_enabled=”off” button_two_text_color__hover_enabled=”off” button_border_width__hover_enabled=”off” button_one_border_width__hover_enabled=”off” button_two_border_width__hover_enabled=”off” button_border_color__hover_enabled=”off” button_one_border_color__hover_enabled=”off” button_two_border_color__hover_enabled=”off” button_border_radius__hover_enabled=”off” button_one_border_radius__hover_enabled=”off” button_two_border_radius__hover_enabled=”off” button_letter_spacing__hover_enabled=”off” button_one_letter_spacing__hover_enabled=”off” button_two_letter_spacing__hover_enabled=”off” button_bg_color__hover_enabled=”off” button_one_bg_color__hover_enabled=”off” button_two_bg_color__hover_enabled=”off”][\/et_pb_contact_field][et_pb_contact_field field_id=”Message” field_title=”Mesajul dvs.” field_type=”text” fullwidth_field=”on” _builder_version=”3.18.9″ button_text_size__hover_enabled=”off” button_one_text_size__hover_enabled=”off” button_two_text_size__hover_enabled=”off” button_text_color__hover_enabled=”off” button_one_text_color__hover_enabled=”off” button_two_text_color__hover_enabled=”off” button_border_width__hover_enabled=”off” button_one_border_width__hover_enabled=”off” button_two_border_width__hover_enabled=”off” button_border_color__hover_enabled=”off” button_one_border_color__hover_enabled=”off” button_two_border_color__hover_enabled=”off” button_border_radius__hover_enabled=”off” button_one_border_radius__hover_enabled=”off” button_two_border_radius__hover_enabled=”off” button_letter_spacing__hover_enabled=”off” button_one_letter_spacing__hover_enabled=”off” button_two_letter_spacing__hover_enabled=”off” button_bg_color__hover_enabled=”off” button_one_bg_color__hover_enabled=”off” button_two_bg_color__hover_enabled=”off”][\/et_pb_contact_field][\/et_pb_contact_form][\/et_pb_column][et_pb_column type=”2_5″ _builder_version=”3.25″ custom_padding=”|||” custom_padding__hover=”|||”][et_pb_text _builder_version=”4.0.11″ text_font=”Kaushan Script||||||||” text_text_color=”#f0622a” text_font_size=”30px” header_font=”||||||||” background_layout=”dark”]<\/p>\n
Operatorul PDI 2020<\/p>\n
[\/et_pb_text][et_pb_text _builder_version=”4.0.11″ text_font=”||||||||”]<\/p>\n
![\"\"](\"https:\/\/pdi.ro\/2021\/wp-content\/uploads\/2020\/02\/eventer_logo_150px.png\")
<\/span><\/p>\n<\/span><\/p>\n<\/span><\/p>\nAdresa: Str. A. Panu nr. 13, Iasi<\/span>
Tel.: 0332.40.88.00-05<\/span>
E-mail: inscrieri@primaderma.ro<\/a>
<\/span>Website:\u00a0<\/span>www.eventernet.ro<\/a><\/p>\n[\/et_pb_text][et_pb_text disabled_on=”off|off|off” _builder_version=”4.0.11″ text_font=”Kaushan Script||||||||” text_text_color=”#f0622a” text_font_size=”30px” header_font=”||||||||” background_layout=”dark” locked=”off”]<\/p>\n
Parteneri Media<\/p>\n
[\/et_pb_text][et_pb_gallery gallery_ids=”7203,7204,7232,7231″ fullwidth=”on” _builder_version=”4.0.11″ transform_scale=”86%|86%” max_width=”63%” auto=”on” auto_speed=”3500″ hover_transition_duration=”100ms” hover_transition_delay=”50ms” hover_transition_speed_curve=”ease-in-out” locked=”off”][\/et_pb_gallery][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"
Prof. Dr.\u00a0Deleanu Diana Universitatea de Medicin\u0103 \u0219i Farmacie”Iuliu Ha\u021bieganu”, Cluj NapocaInhibitorii JAK kinazelor in dermatita atopicaAutori: Diana Deleanu, Irena Pintea Universitatea de Medicina si Farmacie \u201cIuliu Hatieganu\u201d, Institutul Regional de Gastroenterologie si Hepatologie \u201cProf dr. Octavian Fodor\u201d \u2013 Alergologie; Cluj-Napoca Cuvinte cheie: dermatita atopica, JAK inhibitori, imunomodulare Dermatita atopica (DA) este cea mai frecventa afectiune […]<\/p>\n","protected":false},"author":2,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"class_list":["post-7510","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/pdi.ro\/2021\/wp-json\/wp\/v2\/pages\/7510","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pdi.ro\/2021\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/pdi.ro\/2021\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/pdi.ro\/2021\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/pdi.ro\/2021\/wp-json\/wp\/v2\/comments?post=7510"}],"version-history":[{"count":9,"href":"https:\/\/pdi.ro\/2021\/wp-json\/wp\/v2\/pages\/7510\/revisions"}],"predecessor-version":[{"id":10325,"href":"https:\/\/pdi.ro\/2021\/wp-json\/wp\/v2\/pages\/7510\/revisions\/10325"}],"wp:attachment":[{"href":"https:\/\/pdi.ro\/2021\/wp-json\/wp\/v2\/media?parent=7510"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
<\/strong><\/span><\/p>\n <\/strong><\/span><\/p>\n [\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=”3.25″ locked=”off”][et_pb_column type=”4_4″ _builder_version=”3.25″ custom_padding=”|||” custom_padding__hover=”|||”][et_pb_text _builder_version=”4.9.7″ hover_enabled=”0″ sticky_enabled=”0″]<\/p>\n Inhibitorii JAK kinazelor in dermatita atopica Universitatea de Medicina si Farmacie \u201cIuliu Hatieganu\u201d, Institutul Regional de Gastroenterologie si Hepatologie \u201cProf dr. Octavian Fodor\u201d \u2013 Alergologie; Cluj-Napoca<\/p>\n Cuvinte cheie: dermatita atopica, JAK inhibitori, imunomodulare<\/p>\n Dermatita atopica (DA) este cea mai frecventa afectiune inflamatorie cronica a pielii in perioada copilarie, si doar la unii dintre copii se amelioreaza in timp. Mecanismul de producere a DA implica si activarea sistemului imun cu rol important jpentru limfocitele Th2, dar si alte subtipuri de limfocite intervin (Th22, Th1, Th17). Enzimele legate de receptorii membranari pentru citokine, numite JAK kinase reprezinta semnalul al doilea de activare a indusa de citokine, precum IL-4, IL-13, IL-22, IL-23, IL-31, IL-33, IFN-\u03b3. JAK kinazele fosforileaza sistemul STAT (semnalul de activare si traducere a transcriptiei), iar factorii nucleari activati declanseaza sinteza altor citokine. Au fost sintetizate substante ce blocheaza activarea JAK kinazelor. Aceste noi molecule (inhibitorii JAK) au ca efect blocarea activarii limfocitelor si prin aceasta reduc efectele intilnite in boli inflamatorii, printre care se numara si DA. JAK inhibitorii au ca tinta diferite enzime JAK (JAK1, JAK2, JAK3), dar au efecte clinice comune. JAK inhibitorii (baricitinib, tofacitinib etc) se pot administra topic sau oral, iar in studiile clinic (inclusive de faza III) au scazut severitatea simptomelor si semnelor din DA (prurit, eritem etc), siguranta lor fiind mare. Studiile cu aceste medicamente noi, a caror tinta sunt moleculele mici sunt terminate sau in plina desfasurare, astfel incit aprobarea pentru tratamentul DA este aproape. In concluzie. O noua clasa de medicamente, JAK inhibitorii, cu efecte imunomodulatoare si antiinflamatorii, care actioneaza prin blocharea enzimele intracitoplasmatice este la orizont pentru tratamentul DA moderate si severe. JAK inhibitorii sunt eficienti, usor de administrat si au un profil de siguranta mare.<\/p>\n JAK Inhibitors for the treatment of atopic dermatitis University of Medicine & Pharmacy \u201cIuliu Hatieganu\u201d, Regional Institute of Gastroenterology and \u00a0Hepatology \u201cProf dr. Octavian Fodor\u201d \u2013 Allergology; Cluj-Napoca<\/p>\n Key words: atopic dermatitis, JAK inhibitors, immunomodulation<\/p>\n Atopic dermatitis (AD) is one of the most frequent inflammatory skin diseases in childhood, and few of the children out-grow their disease. AD is driven by abnormal immune activation of T helper (Th) 2, but also other subtypes of T cells are involved (Th22, Th1 and Th17). The Janus kinase (JAK)-signal transducer and activator of transcription (STAT) are involved in signaling of several AD-related cytokines, such as IFN-\u03b3, IL-4, IL-13, IL-31, IL-33, IL-23, IL-22, and IL-17, mediating downstream inflammation and barrier alterations. A new class of drugs is developed, and their action is inhibitory on JAK-kinase. The JAK inhibitors, which target different combinations of kinases (JAK1, JAK2, JAK3), have overlapping but distinct mechanisms of action, all of them being efficient and safe. Several topical and oral JAK inhibitors have been shown to decrease AD severity and symptoms. The available data from clinical studies are promising regarding therapeutics and safety effects, so in the next future the approval of JAK inhibitors in AD is expected. In conclusion: a new class of medication, JAK inhibitors, with immunomodulatory and anti-inflammatory effects, acting as inhibitors of intracytoplasmatic enzymes, are on pipe line to be approved in the therapy of AD (moderate and severe). JAK inhibitors are efficient, easy to administrate and the have a safety profile.<\/p>\n Scurt CV<\/span><\/p>\n A absolvit Facultatea de Medicina si Farmacie a Institutului de Medicina si Farmacie Cluj-Napoca (actuala Universitate de Medicina si Farmacie Iuliu Hatieganu) in 1983. Este medic primar de Medicina Interna si de Alergologie si Imunologie Clinica (din 1995). Este angajata la UMF Iuliu Hatieganu, disciplina de Imunologie si Alergologie (sef de disciplina) si la Institutul Regional de Gastroenterologie si Hepatologie (IRGH) \u201cProf. dr. Octavian Fodor\u201d, sectia Medicina Interna (sef de sectie) cu compartimente de Alergologie si de Imunologie. Conduce programul nationale pentru boli rare \u2013 imunodeficiente primare. [\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”3.22″ background_color=”rgba(117,194,33,0.23)” background_image=”https:\/\/pdi.ro\/2021\/wp-content\/uploads\/2020\/02\/back_justflowers_overlay1.png” background_blend=”luminosity” custom_padding=”54px|0px|0|0px|false|false” top_divider_style=”waves2″ top_divider_color=”#ffffff” top_divider_height=”155px” top_divider_height_tablet=”” top_divider_height_phone=”97px” top_divider_height_last_edited=”on|desktop” bottom_divider_style=”waves2″ bottom_divider_color=”#75c221″ bottom_divider_flip=”vertical” bottom_divider_height_tablet=”” bottom_divider_height_phone=”59px” bottom_divider_height_last_edited=”on|desktop”][et_pb_row column_structure=”3_5,2_5″ _builder_version=”3.25″ custom_padding=”61px|0px|69px|0px|false|false”][et_pb_column type=”3_5″ _builder_version=”3.25″ custom_padding=”|||” custom_padding__hover=”|||”][et_pb_text _builder_version=”4.0.11″ text_font=”Kaushan Script||||||||” text_text_color=”#f0622a” text_font_size=”30px” text_line_height=”1.2em” header_font=”||||||||” background_layout=”dark” text_font_size_tablet=”” text_font_size_phone=”” text_font_size_last_edited=”on|desktop”]<\/p>\n Contacteaz\u0103 operatorul PDI 2020<\/p>\n [\/et_pb_text][et_pb_contact_form email=”contact@pdi.ro\/2021\/2019″ submit_button_text=”Trimite mesajul” _builder_version=”3.19.4″ title_font=”||||||||”][et_pb_contact_field field_id=”Name” field_title=”Nume” _builder_version=”3.18.9″ button_text_size__hover_enabled=”off” button_one_text_size__hover_enabled=”off” button_two_text_size__hover_enabled=”off” button_text_color__hover_enabled=”off” button_one_text_color__hover_enabled=”off” button_two_text_color__hover_enabled=”off” button_border_width__hover_enabled=”off” button_one_border_width__hover_enabled=”off” button_two_border_width__hover_enabled=”off” button_border_color__hover_enabled=”off” button_one_border_color__hover_enabled=”off” button_two_border_color__hover_enabled=”off” button_border_radius__hover_enabled=”off” button_one_border_radius__hover_enabled=”off” button_two_border_radius__hover_enabled=”off” button_letter_spacing__hover_enabled=”off” button_one_letter_spacing__hover_enabled=”off” button_two_letter_spacing__hover_enabled=”off” button_bg_color__hover_enabled=”off” button_one_bg_color__hover_enabled=”off” button_two_bg_color__hover_enabled=”off”][\/et_pb_contact_field][et_pb_contact_field field_id=”Email” field_title=”Adresa de e-mail” field_type=”email” _builder_version=”3.19.4″ button_text_size__hover_enabled=”off” button_one_text_size__hover_enabled=”off” button_two_text_size__hover_enabled=”off” button_text_color__hover_enabled=”off” button_one_text_color__hover_enabled=”off” button_two_text_color__hover_enabled=”off” button_border_width__hover_enabled=”off” button_one_border_width__hover_enabled=”off” button_two_border_width__hover_enabled=”off” button_border_color__hover_enabled=”off” button_one_border_color__hover_enabled=”off” button_two_border_color__hover_enabled=”off” button_border_radius__hover_enabled=”off” button_one_border_radius__hover_enabled=”off” button_two_border_radius__hover_enabled=”off” button_letter_spacing__hover_enabled=”off” button_one_letter_spacing__hover_enabled=”off” button_two_letter_spacing__hover_enabled=”off” button_bg_color__hover_enabled=”off” button_one_bg_color__hover_enabled=”off” button_two_bg_color__hover_enabled=”off”][\/et_pb_contact_field][et_pb_contact_field field_id=”Message” field_title=”Mesajul dvs.” field_type=”text” fullwidth_field=”on” _builder_version=”3.18.9″ button_text_size__hover_enabled=”off” button_one_text_size__hover_enabled=”off” button_two_text_size__hover_enabled=”off” button_text_color__hover_enabled=”off” button_one_text_color__hover_enabled=”off” button_two_text_color__hover_enabled=”off” button_border_width__hover_enabled=”off” button_one_border_width__hover_enabled=”off” button_two_border_width__hover_enabled=”off” button_border_color__hover_enabled=”off” button_one_border_color__hover_enabled=”off” button_two_border_color__hover_enabled=”off” button_border_radius__hover_enabled=”off” button_one_border_radius__hover_enabled=”off” button_two_border_radius__hover_enabled=”off” button_letter_spacing__hover_enabled=”off” button_one_letter_spacing__hover_enabled=”off” button_two_letter_spacing__hover_enabled=”off” button_bg_color__hover_enabled=”off” button_one_bg_color__hover_enabled=”off” button_two_bg_color__hover_enabled=”off”][\/et_pb_contact_field][\/et_pb_contact_form][\/et_pb_column][et_pb_column type=”2_5″ _builder_version=”3.25″ custom_padding=”|||” custom_padding__hover=”|||”][et_pb_text _builder_version=”4.0.11″ text_font=”Kaushan Script||||||||” text_text_color=”#f0622a” text_font_size=”30px” header_font=”||||||||” background_layout=”dark”]<\/p>\n Operatorul PDI 2020<\/p>\n [\/et_pb_text][et_pb_text _builder_version=”4.0.11″ text_font=”||||||||”]<\/p>\n <\/span><\/p>\n <\/span><\/p>\n Adresa: Str. A. Panu nr. 13, Iasi<\/span> [\/et_pb_text][et_pb_text disabled_on=”off|off|off” _builder_version=”4.0.11″ text_font=”Kaushan Script||||||||” text_text_color=”#f0622a” text_font_size=”30px” header_font=”||||||||” background_layout=”dark” locked=”off”]<\/p>\n Parteneri Media<\/p>\n [\/et_pb_text][et_pb_gallery gallery_ids=”7203,7204,7232,7231″ fullwidth=”on” _builder_version=”4.0.11″ transform_scale=”86%|86%” max_width=”63%” auto=”on” auto_speed=”3500″ hover_transition_duration=”100ms” hover_transition_delay=”50ms” hover_transition_speed_curve=”ease-in-out” locked=”off”][\/et_pb_gallery][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":" Prof. Dr.\u00a0Deleanu Diana Universitatea de Medicin\u0103 \u0219i Farmacie”Iuliu Ha\u021bieganu”, Cluj NapocaInhibitorii JAK kinazelor in dermatita atopicaAutori: Diana Deleanu, Irena Pintea Universitatea de Medicina si Farmacie \u201cIuliu Hatieganu\u201d, Institutul Regional de Gastroenterologie si Hepatologie \u201cProf dr. Octavian Fodor\u201d \u2013 Alergologie; Cluj-Napoca Cuvinte cheie: dermatita atopica, JAK inhibitori, imunomodulare Dermatita atopica (DA) este cea mai frecventa afectiune […]<\/p>\n","protected":false},"author":2,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"class_list":["post-7510","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/pdi.ro\/2021\/wp-json\/wp\/v2\/pages\/7510","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pdi.ro\/2021\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/pdi.ro\/2021\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/pdi.ro\/2021\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/pdi.ro\/2021\/wp-json\/wp\/v2\/comments?post=7510"}],"version-history":[{"count":9,"href":"https:\/\/pdi.ro\/2021\/wp-json\/wp\/v2\/pages\/7510\/revisions"}],"predecessor-version":[{"id":10325,"href":"https:\/\/pdi.ro\/2021\/wp-json\/wp\/v2\/pages\/7510\/revisions\/10325"}],"wp:attachment":[{"href":"https:\/\/pdi.ro\/2021\/wp-json\/wp\/v2\/media?parent=7510"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}Prof. Dr.\u00a0Deleanu Diana<\/strong><\/span>
Universitatea de Medicin\u0103 \u0219i Farmacie”Iuliu Ha\u021bieganu”, Cluj Napoca<\/strong><\/span><\/h4>\n
Autori: Diana Deleanu, Irena Pintea
<\/span><\/p>\n
Autori: Diana Deleanu, Irena Pintea
<\/span><\/p>\n
Specializari la UMF Cluj-Napoca, UMF Carol Davila, Bucuresti, Universitatea de Medicina Southampton (boli respiratorii), la Spitalul Brompton, Londra, Serviciul de recuperare boli respiratorii Paderborn, la Clinica Nantes, Universitatea Navarra, Clinica San Miguel (alergologie) din Pamplona. Si-a sustinut teza de doctorat in domeniul medicine cu o tema de imunologie, in 1996. Autoare si coautoare a numeroase articole, cu indice Hirsch peste 9 si autoare la mai multe carti, capitole de carte in domeniul imunologiei si alergologiei. A introdus teste de provocare si imunoterapia specifica. Preda cursuri de imunologie si alergologie la studentii de la UMF “Iuliu Hatieganu” Cluj-Napoca, la anul 3 si 6 medicina generala, la medicina dentara, farmacie, nutritie si este responsabila de pregatirea medicilor rezidenti in specialitatea de Alergologie si Imunologie Clinica. Este investigator principal in numeroase studii clinice internationale privind bolile alergice (astm, rinita, soc anafilactic, urticarie). Participant la numeroase manifestarii de medicina, imunologie, alergologie, pediatrie, dermatologie regionale, nationale si internationale. A organizat “Scoala de Vara” 2007 la Cluj-Napoca, impreuna cu Academia Europeana de Alergologie si Imunologie Clinica (EAACI). A fost vicepresedinte (200-2006) si presedinte (2006-20017) al Societatii Nationale de Alergologie si Imunologie Clinica (SRAIC) , in prezent este \u201cfost-presedinte\u201d al SRAIC. Este membra la mai multe societati internationale de alergologie (EAACI, organizatia mondiala de Alergologie \u2013 WAO, la AAAAI, la ACAAI etc) si face parte din Comisiile de specialitate ale MS si Colegiului Medicilor. Are doi copii si trei nepoti.<\/p>\n<\/span><\/p>\n
Tel.: 0332.40.88.00-05<\/span>
E-mail: inscrieri@primaderma.ro<\/a>
<\/span>Website:\u00a0<\/span>www.eventernet.ro<\/a><\/p>\n